Regeneron Officer Marion McCourt Files Form 144 to Sell $984K in Common Stock
REGENERON PHARMACEUTICALS, INC.
Subscribe to track REGN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities Company: REGENERON PHARMACEUTICALS, INC. (REGN) Insider: Marion McCourt (Officer) Shares to Sell: 1,132 Common Shares Estimated Value: $984,194.76 (~$869.43/share) Broker: UBS Financial Services Inc. Trading Plan: Adopted under Rule 10b5-1 on 02/17/2026
Comprehensive Analysis
Overview
On October 30, 2026, Marion McCourt, an Officer of Regeneron Pharmaceuticals, Inc. (REGN), filed a Form 144 notifying the SEC of a proposed sale of 1,132 shares of common stock. The aggregate market value of the securities to be sold is approximately $984,194.76, implying a share price of roughly $869.43.
Transaction Details
- Securities to be Sold: 1,132 Common shares
- Approximate Sale Date: October 30, 2026
- Acquisition Origin: The shares were acquired on December 12, 2023, through the vesting of restricted stock awards (RSA Vesting) directly from the issuer.
- Trading Plan: The proposed sale is conducted pursuant to a Rule 10b5-1 trading plan adopted on February 17, 2026.
Recent Transactions (Past 3 Months)
- September 2, 2026: Sold 1,215 shares for gross proceeds of $1,032,750.00.
- September 3, 2026: Sold 1,131 shares for gross proceeds of $969,708.09.
Market Impact & Significance
The filing represents routine diversification under a pre-established Rule 10b5-1 trading plan. The transaction volume of 1,132 shares is negligible relative to Regeneron's total shares outstanding of over 101.6 million, indicating low market impact.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.